Tetanus and Diphtheria Toxoid-Containing Vaccine in Multiple Sclerosis Patients: A Real-World Prospective, Open-Label, Multi-Centre Study

Tetanus and Diphtheria Toxoid-Containing Vaccine in Multiple Sclerosis Patients: A Real-World Prospective, Open-Label, Multi-Centre Study

<b>Objective</b>: To assess changes in disease activity in Multiple Sclerosis (MS) patients on various disease-modifying-drugs, as well as immunogenicity, safety and clinical tolerability following combined tetanus- and diphtheria-vaccination. <b>Methods</b>: We conducted a p...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexander Winkelmann, Emil C. Reisinger, Katharina Boden, Christoph Metze, Uwe K. Zettl, Micha Loebermann
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Vaccines
Subjects:
multiple sclerosis
tetanus vaccination
diphtheria vaccination
disease-modifying-drugs
immunogenicity
safety
Online Access:https://www.mdpi.com/2076-393X/13/5/451
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-393X/13/5/451

Similar Items